UPDATE : Wednesday, January 17, 2018
상단여백
Pfizer Korea recorded most drug recalls in 2017 by So Jae-hyeon 2018-01-17 13:36
Merck’s Keytruda extends lung cancer survival in pivotal P3 trial by Marian Chu 2018-01-17 12:11
Novartis’ Cosentyx beats out Stelara in 2nd head-to-head trial by Marian Chu 2018-01-17 11:10
Medtronic elects Chris Lee as new Asia-Pacific chief by Marian Chu 2018-01-16 11:15
Huons to upgrade facility to target global eye drop market by Lee Han-soo 2018-01-15 16:21
라인
Hanmi 1st for R&D investment among Korean pharmas by Marian Chu 2018-01-15 15:22
Competition heats up in hair loss treatment market by So Jae-hyeon 2018-01-15 15:02
Hepatitis C drug Mavyret arrives in Korea by Lee Hye-seon 2018-01-15 11:19
Gaucher disease drug effective for retention, early treatment, Sanofi says by Nam Doo-hyun 2018-01-15 10:27
AstraZeneca gets expanded FDA approval for cancer drug by Marian Chu 2018-01-15 10:20
라인
Daewoong gets approval to start Nabota BTX clinical trials in China by Marian Chu 2018-01-11 16:24
Drugmakers work on ‘me-too’ drugs of Pradaxa by Lee Hye-seon 2018-01-11 16:12
Hanmi slates US-based phase 1 trial for LAPSTriple Agonist: CEO by Marian Chu 2018-01-11 15:59
Korean drugmakers promote pipelines at JP Morgan event by So Jae-hyeon 2018-01-11 15:42
Drugmakers speed up ownership successions by So Jae-hyeon 2018-01-11 12:01
라인
AstraZeneca gets go-ahead for biologic asthma drug in Europe by Marian Chu 2018-01-11 10:48
Eli Lilly withdraws testosterone replacement therapy from Korea by Marian Chu 2018-01-10 17:11
Drugmakers play it safe under ‘K-Sunshine Act’ by So Jae-hyeon 2018-01-10 14:23
AbbVie’s atopic dermatitis drug designated ‘breakthrough therapy’ by Marian Chu 2018-01-10 14:13
New antihypertensive combos ready for market entry by Lee Hye-seon 2018-01-09 15:17
여백
여백
여백
Back to Top